Circulating tumor DNA may be an effective biomarker for stratifying patients with small cell lung cancer who would benefit from more stringent follow-ups and clinical trial participation.Patients who ...

The field of liver research has benefited enormously from technological breakthroughs. We now have access to single-cell ...

The defense began Wednesday's proceedings with a testimony from Dr. Maher Noureddine, a forensic DNA evidence consultant, who ...

Accent Therapeutics launched a Phase I/II clinical trial last year to begin testing a small molecule inhibitor of KIF18A in ovarian cancers.

Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today announced it will present new scientific data and platform innovations at the Society for Laboratory Automation ...

Rather than relying on external and 'often meaningless' features, such as greying hair or chronological age, biological age ...

Though transhumanism presents ground-breaking advancements, it challenges ethical and societal values. The integration of ...

Epstein sought to use his own genetic material for regenerative medicine, following his conviction for soliciting ...

Walk into any drugstore and you'll see shelves stacked with bottles promising better health. Millions of people pop vitamins ...

Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia?

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

A two-year study revealed that oak trees subtly shift their microbial communities during drought, recruiting beneficial ...